Literature DB >> 4199563

Rocky Mountain spotted fever: a comparative study of the active immunity induced by inactivated and viable pathogenic Rickettsia rickettsii.

H L DuPont, R B Hornick, A T Dawkins, G G Heiner, I B Fabrikant, C L Wisseman, T E Woodward.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4199563     DOI： 10.1093/infdis/128.3.340

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  20 in total

1.  A recombinant Rickettsia conorii vaccine protects guinea pigs from experimental boutonneuse fever and Rocky Mountain spotted fever.

Authors:  S Vishwanath; G A McDonald; N G Watkins
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

Review 2.  Rocky Mountain spotted fever: a disease in need of microbiological concern.

Authors:  D H Walker
Journal:  Clin Microbiol Rev       Date:  1989-07       Impact factor: 26.132

3.  Molecular basis of immunity to rickettsial infection conferred through outer membrane protein B.

Authors:  Yvonne Gar-Yun Chan; Sean Phillip Riley; Emily Chen; Juan José Martinez
Journal:  Infect Immun       Date:  2011-03-28       Impact factor: 3.441

4.  A protective protein antigen of Rickettsia rickettsii has tandemly repeated, near-identical sequences.

Authors:  B E Anderson; G A McDonald; D C Jones; R L Regnery
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

5.  Humoral immune response to Rocky Mountain spotted fever in experimentally infected guinea pigs: immunoprecipitation of lactoperoxidase 125I-labeled proteins and detection of soluble antigens of Rickettsia rickettsii.

Authors:  J C Williams; D H Walker; M G Peacock; S T Stewart
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

6.  Preparation of Rocky Mountain spotted fever vaccine suitable for human immunization.

Authors:  R H Kenyon; C E Pedersen
Journal:  J Clin Microbiol       Date:  1975-06       Impact factor: 5.948

7.  Phenotype of the anti-Rickettsia CD8(+) T cell response suggests cellular correlates of protection for the assessment of novel antigens.

Authors:  Erika Caro-Gomez; Michal Gazi; Maria A Cespedes; Yenny Goez; Bruno Teixeira; Gustavo Valbuena
Journal:  Vaccine       Date:  2014-07-18       Impact factor: 3.641

8.  Comparison of three rocky mountain spotted fever vaccines.

Authors:  R H Kenyon; L S Sammons; C E Pedersen
Journal:  J Clin Microbiol       Date:  1975-10       Impact factor: 5.948

Review 9.  The realities of biodefense vaccines against Rickettsia.

Authors:  David H Walker
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

10.  Immunological properties of Rickettsia rickettsii purified by zonal centrifugation.

Authors:  R L Anacker; R K Gerloff; L A Thomas; R E Mann; W D Bickel
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.